Purified Serum IgG from a Patient with Anti-IgLON5 Antibody Cause Long-Term Movement Disorders with Impaired Dopaminergic Pathways in Mice
<b>Background</b>: Anti-IgLON5 disease is a rare autoimmune disease of the central nervous system. It typically manifests as a chronic condition, characterized by cognitive impairments, movement disorders, and sleep disorders. The mechanisms underlying movement disorders in this disease...
Main Authors: | Yining Gao, Hongxia Li, Huoqing Luo, You Ni, Yifan Feng, Lu He, Qinming Zhou, Ji Hu, Sheng Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/9/2483 |
Similar Items
-
Patients’ IgLON5 autoantibodies interfere with IgLON5-protein interactions
by: Jon Landa, et al.
Published: (2023-03-01) -
Corrigendum: Patients’ IgLON5 autoantibodies interfere with IgLON5–protein interactions
by: Jon Landa, et al.
Published: (2023-06-01) -
Anti-IgLON5 antibodies cause progressive behavioral and neuropathological changes in mice
by: You Ni, et al.
Published: (2022-06-01) -
Anti-IgLON5 Disease – The Current State of Knowledge and Further Perspectives
by: Natalia Madetko, et al.
Published: (2022-03-01) -
Atypical neurological manifestations in anti-IgLON5 disease: a case report
by: Yun Chen, et al.
Published: (2024-02-01)